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Background: Mammography is a radiological diagnostic method which relies on an X-ray
examination of breasts and is a process involving the use of low-dose amplitude-X-rays
(usually around 0.7mSv). Combining the use of small doses andhigh quality images requires
extensive quality protocols, part of them being included in regulations adopted by the Min-
ister of Health.
Aim: The aim of this study was to check the usefulness and efﬁcacy of selected quality tests
associated with mammography.
Material/methods: The study was performed in the mammography service of the Greater
Poland Cancer Centre in Poznan. Following equipment was used: densitometer, sensito-
meter, mammographic scales, electronic scales, thermometer, hygrometer, PMMA plates,
Europhantom, screen ﬁlm contact phantom, viewing boxes and magnifying glasses. The
methods were based on basic mammography tests. Quality control in mammography
demands: clean darkroom, marked and clean cassettes, clean viewing boxes with homoge-
nous light.
Results: The results of the “Development Process” test show that each sensitometer has to be
used with an appropriate densitometer. Phantoms with abnormal structures cannot be used
to “AEC System – Solidity exposure” test. “Compression – The force of compression” testmay
only be carried out with suitable scales and compressible material. Analysis of rejected ﬁlmsshows that the main reasons for rejection were wrong collimation and underexposure.
Conclusion: Every quality control in mammography provides essential information about
the functioning of a laboratory. Apart from recommended standard sterility, it should be
remembered that equipment should always be adjusted and repaired.
land© 2010 Greater Poammography is a radiological diagnostic method which
elies on an X-ray examination of breasts and is a pro-
ess involving the use of low-dose amplitude-X-rays (usually
round 0.7mSv). The aim of mammography is to detect very
mall abnormalities in the breast tissue before they develop
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into breast cancer, typically through detection of characteris-
tic masses and/or microcalciﬁcations.
Mammography is a very sensitive diagnostic method that
requires very precise equipment and qualiﬁed medical per-
sonnel to perform the examination. Combining the use of
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved
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small doses andhighquality images requires extensivequality
protocols,1,2 part of them being included in regulations or rec-
ommendations adopted by legal scientiﬁc organisations.1,3,4
1. Aim
The aim of this study was to check the usefulness and efﬁcacy
of selected quality tests associated with mammography.
2. Equipment and methods
2.1. Equipment
The study was performed in the mammography service of
the Greater Poland Cancer Centre in Poznan. The following
equipment was used: densitometer, sensitometer, mammo-
graphic scales, electronic scales, thermometer, hygrometer,
PMMA plates, Europhantom, screen ﬁlm contact phantom,
viewing boxes, and magnifying glasses. The manufacturers
and serial numbers are shown in Table 1.
Table 1 – The apparatus used in the Greater Poland Cancer Cen
Apparatus
1. Sensitometer PTW F
2. Sensitometer PTW F
3. Sensitometer Peham
4. Densitometer PTW F
5. Densitometer Peham
6. Densitometer PTW F
7. Mammographic scales Soehn
8. Mammographic scales Nuclea
9. Electronic scales Rinstr
10. Theromometer Testo
11. Theromometer Testo
12. Hygrometer Therm
13. PMMA plates PTW F
14. Europhantom PTW F
15. Screen ﬁlm contact phantom PTW F
16. Viewing box BAKM
17. Magnifying glass HamaFig. 2 – Densitometer SensodensiX PTW Freiburg.
A densitometer was used to measure the optical density of
exposed ﬁlms. This study used three densitometers by three
different manufacturers. The use of each of the three densit-
ometers was tested with each of the three sensitometers. The
sensitometers were used to ensure that the delicate chemi-
cal balance needed to process ﬁlms remains consistent. The
sensitometer generates a consistent exposure time and is con-
sidered constant. The sensitometer must be set to match the
colour spectrum of the test ﬁlm used (in mammography it is
usually green).11,12 Figs. 1 and 2 show the sensitometer and
densitometer used in the study.
3. Methods
3.1. Basic mammography testsQuality control in mammography demands clean darkroom,
marked and clean cassettes, and clean viewing boxes with
homogenous light. It is important to choose a suitable kind
of ﬁlm, chemical reagent, developer and parameters of the
tre for basic tests in mammography.
Manufacturer Serial number
reiburg SensiX T51003-5206
reiburg SensiX T51003-3536
ed 4987
reiburg SensodensiX auto Cal T52004
ed N1031
reiburg SensodensiX T52004-N 1167
le 775507TH00946
r Associates 18-241-44-26
um EWP 0201 27/2006
31618309/604
I-33-02-012 06021293
ohygro –
reiburg –
reiburg T 42024-0109
reiburg T 42022-0020
ED I-48-44-065
–
radiotherapy 1 5 ( 2 0 1 0 ) 145–152 147
d
f
a
e
v
b
p
d
l
t
t
r
m
r
w
w
l
w
p
6
l
e
c
r
T
s
d
0
s
A
s
d
t
w
f
t
b
m
I
0
s
u
m
c
t
m
t
A
c
5
A
t
p
ﬁ
s
o
h
e
re
su
lt
s
of
th
e
d
ev
el
op
m
en
t
p
ro
ce
ss
w
it
h
th
e
u
se
of
se
n
si
to
m
et
er
49
87
an
d
d
en
si
to
m
et
er
10
31
.
Fi
el
d
n
u
m
be
r
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
8
0.
18
0,
18
0.
19
0.
20
0.
22
0.
28
0.
43
0.
82
1.
60
2.
39
3.
05
3.
50
3.
75
4.
02
4.
18
4.
28
4.
37
4.
38
4.
38
8
0.
18
0,
18
0.
20
0.
20
0.
22
0.
28
0.
43
0.
82
1.
59
2.
39
3.
03
3.
51
3.
82
4.
04
4.
18
4.
29
4.
38
4.
38
4.
38
8
0.
18
0.
19
0.
20
0.
20
0.
22
0.
28
0.
45
0.
84
1.
62
2.
44
3.
07
3.
51
3.
82
4.
05
4.
19
4.
28
4.
36
4.
38
4.
38
9
0.
19
0.
20
0.
20
0.
20
0.
22
0.
28
0.
45
0.
83
1.
61
2.
42
3.
06
3.
53
3.
82
4.
05
4.
20
4.
30
4.
38
4.
38
4.
38
8
0.
18
0.
18
0.
20
0.
20
0.
22
0.
27
0.
43
0.
81
1.
59
2.
38
3.
02
3.
50
3.
79
4.
01
4.
15
4.
25
4.
34
4,
37
4.
37
l
d
en
si
ty
8
0.
18
0.
19
0.
20
0.
20
0.
22
0.
28
0.
44
0.
83
1.
60
2.
40
3.
05
3.
51
3.
80
4.
03
4.
18
4.
28
4.
37
4.
38
4.
38
vi
at
io
n
04
0.
00
4
0.
00
8
0.
00
4
0.
00
0.
00
0.
00
4
0.
01
0
0.
01
0
0.
01
2
0.
02
3
0.
01
9
0.
01
1
0.
02
8
0.
01
6
0.
01
7
0.
01
8
0.
01
5
0.
00
4
0.
00
4reports of practical oncology and
evelopment process and ﬁlms storage. Equally signiﬁcant
or the QA process is the choice of a suitable thermometer
nd densitometer, development and reading of sensitograms,
stablishment of a control method, and setting of a reference
alue and tolerance limit. The darkroom was cleaned at the
eginning of each workday, before any ﬁlms were handled or
rocessed. A darkroom should be as free as possible of any
ust or dirt that could result in artefacts in the image. A day-
ight processor for mammography largely eliminates artefacts
hat occur in the process of ﬁlm handling. If the darkroom and
he processor were shared rather than dedicated to mammog-
aphy, mammography quality standards would still have to be
aintained by quality control technicians. Keeping the dark-
oom clean was very important in quality control because it
as the main source of problems. Humidity in the darkroom
as around 40–60%.
All the cassettes and screen-ﬁlms in the mammographic
aboratory were marked. All the cassettes and screen-ﬁlms
ere cleaned once a week. Films were usually kept in tem-
erature lower than 25 ◦C and humidity between 40% and
0%. A digital thermometer was used in the mammographic
aboratory. At the beginning of quality control tests, it was
ssential to assign a reference value and tolerance limit to
ontrol parameters.2
Four tests were made to verify quality control in mammog-
aphy Unit. The ﬁrst test was that of “Process development”.
hree different sensitometers were used: PTW Freiburg Sen-
iX 5206, PTW Freiburg SensiX 3536, Pehamed 4987, and three
ifferent densitometers: PTW Freiburg SensodensiX auto Cal
600, Pehamed 1031, PTW Freiburg SensodensiX 1167. The
tudy applied the mammograph GE Diamond, the developer
GFA Mamoray Compact Plus and a ﬁlm by AGFA. Five mea-
urements were made for each measurement set. The optical
ensity was measured and recorded in 21 boxes. Each line in
he table corresponds toonemeasurement. There areﬁve lines
ith measurements. The mean optical density was derived
romﬁvemeasurements. Thesemeasurementswere alsoused
o calculate the standard deviation to show the difference
etween results. The temperature of the developer in each
easurement was set at 34 ◦C.
The next test was that of AEC System – Solidity exposure.
t involved eight different phantoms and three sensitometers:
600, 1031, and 1167. The third test checked the compres-
ion force. Two compression paddles (small and large) were
sed in this test to measure the force of compression. Three
ammographic scales were used (one of them was bigger and
overed the whole bucky). A small compression paddle and
hree scales were used during the ﬁrst test. Three measure-
ents were made with additional compressible material and
hree without it. The test used Phantom 4.5 cm PMMA, Mode
uto kV and the AEC detector was located in the position
losest to the chest wall. The density was +0.
The fourth test was the “Analysis results of rejected ﬁlms”.
980 mammogram ﬁlms were analysed from April 2006 to
pril 2009. The Mammogram ﬁlms were divided into three
ypes of projection: oblique projection left or right, targeted
rojection, and cranio-caudal projection. The reasons for
lm rejection were: collimation, overexposure, underexpo-
ure, patient motion, artefacts, fog, wrong identiﬁcation, and
thers.
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Table 3 – The results of the development process with the use of sensitometer 4987 and densitometer T 52004-N0600.
Field number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Mean optical density
0.16
0.000.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Standard deviation
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4. Results
4.1. Test no. 1: Process of development
The results of this test show that each sensitometer should
be used with an appropriate densitometer. The sensitome-
ter 4987 has to be used to measure mammograms which
are exposed to the densitometer 1031. When used with an
inappropriate densitometer, all the optical density levels were
incorrectly indicated at 0.16. To measure the optical density,
15 ﬁlms were used. The ﬁlms were divided into three groups
as there were three different measurement sets. The nine
results thus received prove that all the three measurement
sets provide the same results, but only if each sensitometer
is used with an adequate densitometer. In Tables 2 and 3, ﬁve
measurements made with the samesensitometer but differ-
ent densitometer are shown in ﬁve rows. The other tableswith
results are shown in Appendix A.
4.2. Test no. 2: AEC System – Solidity exposure
The test results show that all the three densitometers pro-
vide the same levels of optical densities. The optical density
measured for phantom 7 was higher than 1.80, because this
phantom contains structures which imitate abnormal struc-
tures in female breast. Therefore, this phantom may not be
used in this type of tests. The other phantoms performed their
functions correctly. The optical density of received ﬁlms was
in the range of 1.3–1.8. The results are showed in Table 4.
Table 4 – The results of AEC System test – Solidity exposure.
Item Phantom High voltage
[kV]
1 Large rectangular plexi plates 25
2 Small rectangular plexi plates 24
3 Rectangular plexi plate with circular-shapes 26
4 Semicirrcural plexi plate 26
5 Square plexi plate 24
6 Small square plexi plate 26
7 ACR Phantom 25
8 Europhantom 27
Mean 25.380.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
4.3. Test no. 3: Compression – The force of compression
Three measurements were made with additional compress-
ible material and three without it. In the case of the
measurements without additional compressible material, the
nominal values of the force of compression were at the same
level of 20kg. For scales 2 and 3 they were too high, exceed-
ing 20kg. The force of compression measurement values for
scales 2 and 3 were two times higher than the standard value:
55kg and 49.5 kg, respectively. In the case of measured and
nominal values of the force of compression with additional
compressible material, results were out of limit for scales 2.
The second test wasmadewith a large compression paddle. In
this case, also when scales 2 and 3 were used, the results were
different from the standard levels. The value of the force of
compression measured with phantom on scales 2 was about
8kg higher than the limit value of 20kg. In the other case,
measured and nominal values of the force of compression
were within the limit. The results of this test are presented
in Tables 5 and 6.
4.4. Test no. 4: Analysis of rejected ﬁlms
5980 mammogram ﬁlms were analysed from April 2006 to
April 2009. 32 ﬁlms were replayed and accounted for 0.54%
of all ﬁlms. The main reasons for rejecting ﬁlms in left or
right oblique projection were wrong collimation and under-
exposure. In the case of targeted mammogram ﬁlms, the
main reason for rejection was wrong collimation. Other
reasons for rejection, together with collimation, applied to
Exposure time
[mAs]
Densitometer
T 52004-N0600 N 1031 T-49-031-013
173 1.52 1.50 1.45
66 1.54 1.53 1.55
82 1.52 1.46 1.52
87 1.45 1.42 1.42
83 1.48 1.45 1.45
76 1.45 1.41 1.47
82 1.87 1.8 1.90
74 1.52 1.47 1.55
90.38 1.54 1.51 1.54
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Table 5 – Test results of “Compression test – The force of compression” with the use of small compression paddle.
Mammographic scales EWP0201 18-241-4426 SOEHNLE
Without additional compressible material
Nominal force of compression [kg] 18.0 23.5 21.5
Measured force of compression [kg] 19.6 55.0 49.4
Force of compression after 1min [kg] 18.9 53.8 47.8
With additional compressible material
Nominal force of compression [kg] X 12.0 12.5
Measured force of compression [kg] X 29.8 13.3
Force of compression after 1min [kg] X 28.2 12.6
Table 6 – Test results of Compression test – The force of compression with the us of a large compression paddle.
Mammographic scales EWP0201 18-241-4426 SOEHNLE
Without compressible material
Nominal force of compression [kg] 13.50 25.00 22.50
Measured force of compression [kg] 15.06 26.00 23.80
Force of compression after 1min [kg] 17.70 35.60 21.90
With compressible material
C
(
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o
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r
t
b
I
b
n
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r
a
o
c
t
o
l
a
VNominal force of compression [kg] 13.50
Measured force of compression [kg] 15.06
Force of compression after 1min [kg] 17.70
C projection. Other factors did not inﬂuence the results
Table 7).
. Discussion
he analysis of quality control tests shows that routine control
f medical equipment is necessary when conducting qual-
ty control tests in mammography. Accurate quality control
uarantees high quality of conducted examinations, and con-
equently, a correct diagnosis of the patient on the basis of
esulting mammograms. For the assessments to be consis-
ent, the same assessment image criteria, e.g. density, should
e measured at one reference point, i.e. 6 cm from the chest.
t is also necessary to use a correctly illuminated viewing
ox, keep the same evaluation conditions, and use a mag-
ifying glass as in the case of analysis of mammographic
mages. The roomwheremammograms are performed should
e dimmed by cutting off additional outside light. A cor-
ect use of densitometer and sensitometer sets is essential,
s well as working in compliance with manufacturer’s rec-
mmendations, otherwise results may be misleading. The
hoice of a suitable sensitometer enables a quality control
o be conducted in conditions of irradiation close to those
f clinical examinations. It is important to set a reference
evel and acceptable tolerance range at the beginning of
quality control program in a mammographic laboratory.
alues received while measuring parameters of a correctly
Table 7 – Results of rejected ﬁlms analysis.
Projection Collimation Overexposure
of ﬁlm
Undere
of ﬁ
Oblique projection left or
right
2 1 2
Targeted 3 – –
CC (cranial-caudal view) 7 1 511.50 11.00
28.00 12.45
11.50 11.90
functioning system during routine work serve as reference
levels.
As shown by the examination results, all the three densit-
ometers in the Greater Poland Cancer Centre measured the
optical density equally. The examination results show clearly
that the densitometer 4987 is the only one to be used to
measure the density of mammographic ﬁlm irradiated by the
sensitometer 1031. To carry out basic quality control tests, it
is recommended to use a sensitometer and densitometer by
the samemanufacturer. A failure to followmanufacturer’s rec-
ommendations may result in erroneous interpretation of the
results. Using the abovementioned sensitometerwith another
densitometer proved wrong as all the results achieved were at
the same level of 0.16. All the three sets of sensitometers and
densitometers show similar levels and fall within the range of
standard quantities. To carry out AEC System test, it is highly
important to avoid using a phantom featuring various hid-
den structures imitating irregularities in female breasts. Other
phantoms can be freely used in the test. The use of match-
ing phantoms is essential as each test requires a different
phantom. To measure the strength of compression, it is rec-
ommended to use digital scales which should be set in the
place of breast placement during clinical research. The out-
come is similar for a rolled towel used as a phantom. It allows
an actual measurement. Regular scales are not recommended
for this test as they are not precise enough. While carrying out
quality control tests, it is also essential to pay attention to the
xposure
lm
Patient
motion
Artefacts Fog Identiﬁcation Other
– – – – –
– – – – 1
2 – – – 8
d rad150 reports of practical oncology an
possibility of artefacts appearing in mammograms. Artefacts
are likely to distort the information about the object under
examination. The main reason for artefacts to appear may be
the darkroom. Artefacts can be caused by external conditions
(diagnostic equipment) or mistakes made by people conduct-
ing quality control tests and clinical examinations. Artefacts
can be observed on the entire area of the picture. Most dan-
gerous are those appearing in the area of a diagnosed organ
and blurring the image. When similar to anatomic structures
to be detected, they create the risk of wrong decisions, thus
lowering the efﬁcacy of the examination.
6. ConclusionAll the three measurement sets used in the test development
process provide the same results but only with a properly
matched sensitometer and densitometer.
Table 8 – Results of the development process with the use of se
52004-N0600.
Box nu
1 2 3 4 5 6 7 8 9 10 11
0.18 0.17 0.18 0.18 0.18 0.18 0.20 0.26 0.43 0.83 1.53
0.17 0.17 0.18 0.18 0.18 0.18 0.21 0.27 0.44 0.86 1.58
0.16 0.16 0.16 0.17 0.18 0.18 0.20 0.26 0.43 0.84 1.57
0.16 0.16 0.16 0.17 0.18 0.18 0.20 0.26 0.43 0.84 1.56
0.16 0.16 0.17 0.17 0.18 0.18 0.20 0.27 0.44 0.86 1.59
Mean optical density
0.17 0.82 0.34 0.17 0.18 0.18 0.20 0.26 0.43 0.85 1.57
Standard deviation
0.009 0.005 0.010 0.005 0.000 0.000 0.004 0.005 0.005 0.013 0.023
Table 9 – Results of the development process with the use of se
Box nu
1 2 3 4 5 6 7 8 9 10 11
0.18 0.18 0.18 0.18 0.18 0.20 0.22 0.28 0.44 0.85 1.58
0.18 0.18 0.18 0.18 0.18 0.20 0.22 0.28 0.46 0.89 1.64
0.18 0.18 0.18 0.18 0.18 0.19 0.22 0.28 0.45 0.88 1.63
0.18 0.18 0.18 0.18 0.18 0.19 0.22 0.28 0.45 0.87 1.63
0.18 0.18 0.18 0.18 0.18 0.20 0.22 0.28 0.46 0.89 1.65
Mean optical density
0.18 0.18 0.18 0.18 0.18 0.20 0.22 0.28 0.45 0.88 1.63
Standard deviation
0.000 0.000 0.000 0.000 0.000 0.005 0.000 0.000 0.008 0.017 0.027iotherapy 1 5 ( 2 0 1 0 ) 145–152
The “AEC System – Solidity exposure” test has to be car-
ried out with a phantom which is intended for this test. Using
unsuitable phantom can delivermisleading results. Phantoms
containing structures which resemble abnormal structures
in female breast near the measurement point may not be
used.
The “Compression – The force of compression” test may
only be carried out with suitable scales and compressible
material.
The analysis of rejected ﬁlms shows that the main reason
for rejection of ﬁlms was wrong collimation and underexpo-
sure.Appendix A.
See Tables 8–14.
nsitometer T 51003-5206 and densitometer T
mber
12 13 14 15 16 17 18 19 20 21
2.28 2.96 3.42 3.75 3.99 4.15 4.26 4.34 4.43 4.52
2.34 3.01 3.46 3.79 4.02 4.18 4.28 4.36 4.45 4.55
2.34 3.02 3.46 3.78 4.03 4.18 4.28 4.36 4.45 4.46
2.34 3.01 3.47 3.79 4.02 4.17 4.28 4.36 4.45 4.55
2.34 3.01 3.46 3.79 4.01 4.15 4.25 4.34 4.43 4.52
2.33 3.00 3.45 3.78 4.01 4.17 4.27 4.35 4.44 4.52
0.027 0.024 0.019 0.017 0.015 0.015 0.014 0.011 0.011 0.037
nsitometer T 51003-5206 and densitometer T 49-031-013.
mber
12 13 14 15 16 17 18 19 20 21
2.35 3.01 3.45 3.78 4.00 4.15 4.26 4.35 4.43 4.52
2.42 3.07 3.51 3.83 4.05 4.20 4.31 4.39 4.48 4.57
2.43 3.09 3.51 3.82 4.05 4.20 4.31 4.39 4.47 4.48
2.41 3.09 3.52 3.83 4.04 4.19 4.31 4.39 4.47 4.48
2.42 3.08 3.50 3.82 4.03 4.16 4.27 4.35 4.43 4.45
2.41 3.07 3.50 3.82 4.03 4.18 4.29 4.37 4.46 4.50
0.032 0.033 0.028 0.021 0.021 0.023 0.025 0.022 0.024 0.046
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Table 10 – Results of the development process with the use of sensitometer T 51003-5206 and densitometer T N 1031.
Box number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Mean optical density
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Standard deviation
0.000 0.000 00.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Table 11 – Results of the development process with the use of sensitometer 4987 and densitometer T-49-031-013.
Box number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Mean optical density
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Standard deviation
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Table 12 – Results of the development process of the use of sensitometer T 51003-3536 and densitometer T 49-031-013.
Box number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
0.17 0.17 0.18 0.18 0.18 0.18 0.20 0.24 0.38 0.72 1.36 2.16 2.96 3.49 3.84 4.06 4.22 0.17 0.17 0.18 0.18
0.18 0.18 0.18 0.18 0.18 0.18 0.20 0.24 0.38 0.71 1.37 2.17 2.95 3.49 3.83 4.06 4.21 0.18 0.18 0.18 0.18
0.18 0.18 0.18 0.18 0.18 0.19 0.20 0.25 0.40 0.74 1.38 2.18 2.97 3.51 3.85 4.07 4.22 0.18 0.18 0.18 0.18
0.18 0.18 0.18 0.19 0.18 0.19 0.20 0.25 0.40 0.74 1.38 2.18 2.98 3.55 3.88 4.09 4.24 0.18 0.18 0.18 0.19
0.19 0.19 0.19 0.19 0.19 0.19 0.21 0.25 0.40 0.73 1.38 2.19 2.97 3.52 3.86 4.08 4.23 0.19 0.19 0.19 0.19
Mean optical density
0.18 0.18 0.18 0.18 0.18 0.19 0.20 0.25 0.39 0.73 1.37 2.18 2.97 3.51 3.85 4.07 4.22 0.18 0.18 0.18 0.18
Standard deviation
0.007 0.007 0.004 0.005 0.004 0.005 0.004 0.005 0.011 0.013 0.009 0.011 0.011 0.025 0.019 0.013 0.011 0.007 0.007 0.004 0.005
Table 13 – The results of the development process with the use of sensitometer T 51003-3536 and densitometer T
52004-N0600.
Box number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
0.16 0.16 0.16 0.17 0.18 0.18 0.2 0.24 0.37 0.69 1.34 2.14 2.91 3.45 3.83 4.05 0.16 0.16 0.16 0.17 0.18
0.17 0.18 0.18 0.18 0.18 0.18 0.2 0.24 0.37 0.69 1.34 2.15 2.9 3.46 3.82 4.05 0.17 0.18 0.18 0.18 0.18
0.18 0.18 0.18 0.18 0.18 0.18 0.2 0.24 0.39 0.71 1.36 2.16 2.92 3.48 3.85 4.07 0.18 0.18 0.18 0.18 0.18
0.18 0.18 0.18 0.18 0.18 0.18 0.2 0.24 0.38 0.71 1.36 2.14 2.92 3.51 3.87 4.07 0.18 0.18 0.18 0.18 0.18
0.18 0.18 0.18 0.18 0.18 0.18 0.2 0.24 0.37 0.7 1.36 2.15 2.91 3.48 3.85 4.06 0.18 0.18 0.18 0.18 0.18
Mean optical density
0.17 0.18 0.18 0.18 0.18 0.18 0.20 0.24 0.38 0.70 1.35 2.15 2.91 3.48 3.84 4.06 0.17 0.18 0.18 0.18 0.18
Standard deviation
0.009 0.009 0.009 0.004 0.000 0.000 0.000 0.000 0.009 0.010 0.011 0.008 0.008 0.023 0.019 0.010 0.009 0.009 0.009 0.004 0.000
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Table 14 – Results of the process of developing with the use of sensitometer T 51003-3536 and densitometer N 1031.
Box number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
Mean optical density
0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16 0.16
0.00
r
1
1
FStandard deviation
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
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